MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
about
The expanding regulatory universe of p53 in gastrointestinal cancerEmerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implicationsDysregulation of non-coding RNAs in gastric cancerThe functional sites of miRNAs and lncRNAs in gastric carcinogenesisRole of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancerIdentification and characterization of novel and conserved microRNAs in several tissues of the Chinese rare minnow (Gobiocypris rarus) based on illumina deep sequencing technologymiR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer.MicroRNA analysis suggests an additional level of feedback regulation in the NF-κB signaling cascademiR-215 promotes malignant progression of gastric cancer by targeting RUNX1MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemiaExpression profiling and functional characterization of miR-192 throughout sheep skeletal muscle developmentMicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer.The p53/microRNA connection in gastrointestinal cancer.Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundariesMicroRNA-215 enhances invasion and migration by targeting retinoblastoma tumor suppressor gene 1 in high-grade glioma.Diagnostic and prognostic values of tissue hsa-miR-30c and hsa-miR-203 in prostate carcinoma.Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of ImatinibMicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1.Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer.MiR-215/192 participates in gastric cancer progression.Identification and Evaluation of Novel MicroRNA Biomarkers in Plasma and Feces Associated with Drug-induced Intestinal Toxicity.The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma.SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.miR-215 functions as an oncogene in high-grade glioma by regulating retinoblastoma 1.Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.
P2860
Q26742058-2E51256B-0910-4132-9257-18F75B24C747Q26774498-0A131306-E19F-4E35-97A3-1D3EE3F2A785Q26780293-B54B5BF2-5ECA-4025-8244-EB39131E11D7Q27026837-15915FC1-9724-42A0-AAEC-28D472670314Q28067449-A083CEE8-886F-4E1B-85D9-0E2B59A3A829Q35986240-16A9C45E-CA59-4B65-AF3D-3304721EDED0Q36085367-849DF954-32C8-4420-A3AF-52A579B1A2EFQ36231978-7CC0B0FB-C607-4C6D-A32E-5C9605B8252FQ36782595-5CFFE8A5-D8B2-418E-892C-21EE4484FE32Q36914209-58E10BB5-5313-4FBC-827E-94CB63BE723AQ36949308-2F1CB786-B577-48F7-93E8-6CC41C4F083EQ37121701-DA4A920D-69D3-4550-8411-A0C4A2FC8EA2Q37685240-CABCA326-0623-4FCD-8662-CED72C42C7C6Q38261312-1F7007FD-39C1-49FC-8487-A122A18CB9D5Q38514962-EA667FDC-E699-479B-A873-DE4001FE7F25Q38634656-298059C0-2C86-48BE-9EE0-283657A15566Q38731609-0303EADE-388D-4DBE-8D1B-B3C74F9E6DE2Q40394844-225CEA39-EC4D-4B88-85C1-0105CEF32E35Q40752763-8C9D17C6-5273-48D4-A717-3EF075E572E7Q40979424-BB7357A4-2F56-4600-9068-23D3F87E9E91Q42315821-08F23232-67BA-4CD1-B887-EE9A93B27E8EQ42366537-5392FCE1-F93B-4F85-9286-3D1215B06688Q46066034-4337E7EF-E175-4312-BFC9-8EA4F3499423Q46155121-3D0D4C1D-6F47-419B-87BB-FE627E3F4B4BQ47831650-2FB6EDCD-B73B-48CA-A06B-EE4E339C064BQ50416566-3A62BCE5-E33B-4896-AFC7-03FCF5BF431CQ53251302-C6ED9C0E-610E-48A0-89BC-3BCB9F398FBEQ53632731-DB41A405-63B9-48F8-ACAF-BA1DA8A4F41EQ55403266-C4373727-ECB4-4357-8B28-0A5EA20847E1
P2860
MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
@en
MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
@nl
type
label
MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
@en
MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
@nl
prefLabel
MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
@en
MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
@nl
P2093
P1433
P1476
MiR-215 modulates gastric cancer cell proliferation by targeting RB1
@en
P2093
Cheng Zhang
Jianmin Si
Liangjing Wang
Minhong Shen
Xiaojia Wang
Xiaoyi Yan
Xuting Zhang
P356
10.1016/J.CANLET.2013.08.033
P407
P50
P577
2013-08-24T00:00:00Z